Free Trial
ASX:CSL

CSL (CSL) Stock Price, News & Analysis

CSL logo

About CSL Stock (ASX:CSL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
869,289 shs
Average Volume
N/A
Market Capitalization
$77.43 billion
P/E Ratio
28.02
Dividend Yield
1.56%
Price Target
N/A
Consensus Rating
N/A

Company Overview

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Remove Ads
Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSL Stock News Headlines

Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

CSL Stock Analysis - Frequently Asked Questions

CSL Limited (ASX:CSL) issued its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 EPS for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a net margin of 18.41% and a trailing twelve-month return on equity of 15.37%.

Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD).

Company Calendar

Last Earnings
8/14/2019
Ex-Dividend for 4/8 Dividend
3/09/2025
Today
4/03/2025
Record date for 4/8 Dividend
4/08/2025
Dividend Payable
4/08/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Rubber And Plastic Products
Current Symbol
ASX:CSL
CIK
N/A
Fax
N/A
Employees
12,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
28.02
Forward P/E Ratio
N/A
P/E Growth
1.29
Net Income
$2.64 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.80 billion
Price / Cash Flow
207.70
Book Value
A$42.52 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$77.43 billion
Optionable
Not Optionable
Beta
0.32
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (ASX:CSL) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners